Dx Deals: Labcorp Acquires Stake in European Testing Giant
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
From - Laboratory Industry Report
Changes to Medicare Part B payment for lab tests mandated by the Protecting Access to Medicare Act of 2014 (PAMA) take effect on…
From - Laboratory Industry Report
The U.S. Drug Enforcement Administration's latest National Take-Back Initiative happens this month on Oct. 22, when the public is…
From - Laboratory Industry Report
As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to…
From - Laboratory Industry Report
Provista Diagnostics, a New York City-based molecular laboratory has concluded that the age of patients can play a role in the…